Is islet transplantation a realistic approach to curing diabetes?
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Since the report of type 1 diabetes reversal in seven consecutive patients by the Edmonton protocol in 2000, pancreatic islet transplantation has been reappraised based on accumulated clinical evidence. Although initially expected to therapeutically target long-term insulin independence, islet transplantation is now indicated for more specific clinical benefits. With the long-awaited report of the first phase 3 clinical trial in 2016, allogeneic islet transplantation is now transitioning from an experimental to a proven therapy for type 1 diabetes with problematic hypoglycemia. Islet autotransplantation has already been therapeutically proven in chronic pancreatitis with severe abdominal pain refractory to conventional treatments, and it holds promise for preventing diabetes after partial pancreatectomy due to benign pancreatic tumors. Based on current evidence, this review focuses on islet transplantation as a realistic approach to treating diabetes.
Abstract
Since the report of type 1 diabetes reversal in seven consecutive patients by the Edmonton protocol in 2000, pancreatic islet transplantation has been reappraised based on accumulated clinical evidence. Although initially expected to therapeutically target long-term insulin independence, islet transplantation is now indicated for more specific clinical benefits. With the long-awaited report of the first phase 3 clinical trial in 2016, allogeneic islet transplantation is now transitioning from an experimental to a proven therapy for type 1 diabetes with problematic hypoglycemia. Islet autotransplantation has already been therapeutically proven in chronic pancreatitis with severe abdominal pain refractory to conventional treatments, and it holds promise for preventing diabetes after partial pancreatectomy due to benign pancreatic tumors. Based on current evidence, this review focuses on islet transplantation as a realistic approach to treating diabetes.
참고문헌 (21)
- Shapiro AM, "Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen", N Engl J Med, 343, pp.230~238 (2000)
- 김재현, "췌도이식의 과거, 현재 및 미래", 대한내과학회지, 75(3), pp.274~279 (2008), 대한내과학회
- Kim KW., "Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus", Diabetes Res Clin Pract, 66(Suppl 1), pp.S11~S17 (2004)
- Dunn TB, "Beta-cell replacement therapy: current outcomes and future landscape", Curr Opin Organ Transplant, 20, pp.681~690 (2015)
- Choudhary P, "Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia", Diabetes Care, 38, pp.1016~1029 (2015)
- Venstrom JM, "Survival after pancreas transplantation in patients with diabetes and preserved kidney function", JAMA, 290, pp.2817~2823 (2003)
- Barton FB, "Improvement in outcomes of clinical islet transplantation: 1999-2010", Diabetes Care, 35, pp.1436~1445 (2012)
- Hering BJ, "Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia", Diabetes Care, 39, pp.1230~1240 (2016)
- Shinichi Matsumoto, "Clinical Allogeneic and Autologous Islet Cell Transplantation: Update", Diabetes and Metabolism Journal, 35(3), pp.199~206 (2011), 대한당뇨병학회
- Jin SM, "Diabetes-free survival in patients who underwent islet autotransplantation after 50% to 60% distal partial pancreatectomy for benign pancreatic tumors", Transplantation, 95, pp.1396~1403 (2013)
- Ryan EA, "Five-year follow-up after clinical islet transplantation", Diabetes, 54, pp.2060~2069 (2005)
- Bellin MD, "Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes", Am J Transplant, 12, pp.1576~1583 (2012)
- Lehmann R, "Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up", Diabetes Care, 38, pp.752~759 (2015)
- Lablanche S, "Five-year metabolic, functional, and safety results of patients with type 1 diabetes transplanted with allogenic islets within the Swiss-French GRAGIL network", Diabetes Care, 38, pp.1714~1722 (2015)
- Yang TY, "First human trial of pancreatic islet allo-transplantation in Korea: focus on re-transplantation", Diabetes Res Clin Pract, 56, pp.107~113 (2002)
- 양혜경, "Reversal of Hypoglycemia Unawareness with a Single-donor, Marginal Dose Allogeneic Islet Transplantation in Korea: A Case Report", Journal of Korean Medical Science, 30(7), pp.991~994 (2015), 대한의학회
- Forlenza GP, "Successful application of closed-loop artificial pancreas therapy after islet autotransplantation", Am J Transplant, 16, pp.527~534 (2016)
- Jung HS, "A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors", Clin Transplant, 21, pp.738~743 (2007)
- Jung HS, "Enhancement of beta-cell regeneration by islet transplantation after partial pancreatectomy in mice", Transplantation, 88, pp.354~359 (2009)
- Oh BJ, "Co-culture with mature islet cells augments the differentiation of insulin-producing cells from pluripotent stem cells", Stem Cell Rev, 11, pp.62~74 (2015)
- Jung HS, "Healthy twin birth after autologous islet transplantation in a pancreatectomized patient due to a benign tumor", Transplant Proc, 39, pp.1723~1725 (2007)